These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 16818278)
1. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells. de Vries JF; Falkenburg JH; Willemze R; Barge RM Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278 [TBL] [Abstract][Full Text] [Related]
2. Ara-C induces apoptosis in resting B-CLL cells independent on cell proliferation, but involving Ara-CTP formation and inhibition of RNA synthesis. Kolb JP Haematologica; 2006 Jul; 91(7):868. PubMed ID: 16818268 [No Abstract] [Full Text] [Related]
3. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887 [TBL] [Abstract][Full Text] [Related]
4. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
6. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055 [TBL] [Abstract][Full Text] [Related]
7. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill. Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163 [TBL] [Abstract][Full Text] [Related]
10. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells. Bairey O; Vanichkin A; Shpilberg O Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e77-85. PubMed ID: 19208092 [TBL] [Abstract][Full Text] [Related]
11. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Pettitt AR; Sherrington PD; Cawley JC Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
13. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells]. Lei XY; Zhang H; He DM Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735 [TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity. Bruno S; Ghiotto F; Tenca C; Mazzarello AN; Bono M; Luzzi P; Casciaro S; Recchia A; Decensi A; Morabito F; Fais F Leukemia; 2012 Oct; 26(10):2260-8. PubMed ID: 22475870 [TBL] [Abstract][Full Text] [Related]
16. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step. Rodriguez CO; Gandhi V Cancer Res; 1999 Oct; 59(19):4937-43. PubMed ID: 10519407 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines. Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine. Balakrishnan K; Wierda WG; Keating MJ; Gandhi V Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456 [TBL] [Abstract][Full Text] [Related]
19. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro. Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398 [TBL] [Abstract][Full Text] [Related]
20. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling. Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]